SANDS LAB Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	12,725	11,612	8,297
Revenue Growth (YoY)	58.34%	39.96%	-
Gross Profit	12,725	11,612	8,297
Selling, General & Admin	10,726	10,225	9,744
Research & Development	2,156	2,021	1,522
Amortization of Goodwill & Intangibles	167.59	134.11	83.18
Operating Expenses	14,058	13,382	12,006
Operating Income	-1,333	-1,770	-3,709
Interest Expense	-0.27	-0.35	-9.34
Interest & Investment Income	936.42	1,012	1,371
Other Non Operating Income (Expenses)	-70.65	-64.48	-52.32
EBT Excluding Unusual Items	-461.29	-822.94	-2,399
Gain (Loss) on Sale of Investments	1,324	783.03	-390.6
Gain (Loss) on Sale of Assets	-	2.89	2.56
Pretax Income	862.65	-37.02	-2,787
Income Tax Expense	428.44	428.44	-486.95
Earnings From Continuing Operations	434.21	-465.47	-2,301
Minority Interest in Earnings	-77.8	-84.18	-
Net Income	356.41	-549.64	-2,301
Net Income to Common	356.41	-549.64	-2,301
Shares Outstanding (Basic)	15	15	14
Shares Outstanding (Diluted)	15	15	14
Shares Change (YoY)	5.27%	6.84%	-
EPS (Basic)	23.31	-36.23	-162.00
EPS (Diluted)	23.31	-36.23	-162.00
Free Cash Flow	-822.3	-269.9	-5,815
Free Cash Flow Per Share	-53.78	-17.79	-409.47
Gross Margin	100.00%	100.00%	100.00%
Operating Margin	-10.47%	-15.25%	-44.70%
Profit Margin	2.80%	-4.73%	-27.73%
Free Cash Flow Margin	-6.46%	-2.32%	-70.08%
EBITDA	-156.09	-632.81	-2,918
EBITDA Margin	-1.23%	-5.45%	-35.17%
D&A For EBITDA	1,176	1,138	791.1
EBIT	-1,333	-1,770	-3,709
EBIT Margin	-10.47%	-15.25%	-44.70%